by Universidad Politécnica de Madrid An international team of researchers, in which a researcher from Universidad Politécnica de Madrid is involved, has identified one of the main causes of food allergy in the Mediterranean area. Recently, a research team led by Dr. Araceli Díaz Perales from Centre for Plant Biotechnology and Genomics (CBGP, UPM-INIA), in collaboration with other...
Tag: <span>Asthma</span>
Post
A new drug promises to lower risks of asthma attack
by Himanshu Kaul, The Conversation A recent study shows that a gamechanger drug called Fevipiprant promises to lower patients’ risks of suffering an asthma attack and being admitted to a hospital. This is the first time a drug reducing airway smooth muscle mass—a key clinical indicator of disease severity that increases the likelihood of more frequent...
Post
Likelihood of tick bite to cause red meat allergy could be higher than previously thought
Until now it has been believed that in order for a tick to trigger an allergic immune response to alpha-gal in humans, the tick would need to have recently fed on the alpha-gal-rich blood of a mammal. New research from the UNC School of Medicine presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) annual conference in San...
Post
Asthma pill targets airway muscles to decrease attacks
Results from a phase II clinical trial, experimental work on cells and computational modelling have together shown why the first pill for asthma in 20 years can help reduce asthma attacks. Credit: ECN Researchers from Leicester (UK) and Vancouver (Canada) have shown that the investigational drug, Fevipiprant (an oral, selective prostaglandin D2 receptor antagonist), reduces...
Post
Vitamin D intake and obesity in occupational asthma patients and need for supplementation
The article by Dr. Marina Ruxandra Otelea and Dr. Agripina Rascu is published in Endocrine, Metabolic & Immune Disorders – Drug Targets, Volume 18, Issue 6, 2018 BENTHAM SCIENCE PUBLISHERS IMAGE: THE RESEARCH WAS CONDUCTED TO ASSESS THE VITAMIN D INTAKE IN OCCUPATIONAL ASTHMA PATIENTS AND THE RELATION WITH BODY MASS INDEX, COMORBIDITIES RELATED TO VITAMIN D DEFICIT, LUNG FUNCTION AND. CREDIT: DR. MARINA RUXANDRA OTELEA, DR. AGRIPINA...
Post
Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
Teva Pharmaceutical, based in Israel, landed the first FDA approval for a digital inhaler with built-in sensors. The ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder is indicated for people suffering from asthma & COPD as a way of preventing and treating bronchospasm, a tightening of the muscles that line the airways. The ProAir Digihaler...
Post
Groundbreaking app detects a child’s risk of asthma in just SIX yes or no questions
App – called PARS – asks about wheezing and if the child’s parents suffer Score of zero-to-15 estimates if the youngster will suffer by seven years old Avoids the need for blood tests, which are used to diagnose the condition A new smartphone app that has been developed by scientists can detect a child’s risk...
Post
Next-generation asthma inhalers
In Europe alone, there are almost 30 million people who suffer from asthma. The myAirCoach project provides an innovative smart inhaler device along with integrated mobile Health (mHealth) personalized asthma monitoring services for empowering and guiding patients with asthma to manage their own health on a daily basis. Credit: Konstantinos Votis Asthma, a chronic inflammatory disease of...
Post
FDA approves return of popular Primatene Mist asthma inhaler
A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores.The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It’s for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up. This undated product image provided by Amphastar shows Primatene Mist. A new version...
Post
Pathway to resolve allergic asthma is discovered
A group of Brazilian researchers succeeded in preventing allergic asthma from progressing in experimental models by increasing the amount of a protein. This increase, in turn, blocked the CD4+ T lymphocytes responsible for producing a cytokine that triggers a cascade of events resulting in the onset and progression of the disease. This knowledge of how...